302 related articles for article (PubMed ID: 19922649)
1. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.
Kalman DS; Schwartz HI; Alvarez P; Feldman S; Pezzullo JC; Krieger DR
BMC Gastroenterol; 2009 Nov; 9():85. PubMed ID: 19922649
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort.
Soman RJ; Swamy MV
Int J Colorectal Dis; 2019 Nov; 34(11):1971-1978. PubMed ID: 31686199
[TBL] [Abstract][Full Text] [Related]
3. The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study.
Majeed M; Nagabhushanam K; Paulose S; Arumugam S; Mundkur L
Medicine (Baltimore); 2023 Mar; 102(9):e33109. PubMed ID: 36862903
[TBL] [Abstract][Full Text] [Related]
4. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
Hun L
Postgrad Med; 2009 Mar; 121(2):119-24. PubMed ID: 19332970
[TBL] [Abstract][Full Text] [Related]
5. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
Majeed M; Nagabhushanam K; Natarajan S; Sivakumar A; Ali F; Pande A; Majeed S; Karri SK
Nutr J; 2016 Feb; 15():21. PubMed ID: 26922379
[TBL] [Abstract][Full Text] [Related]
6. A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.
Maity C; Gupta AK
Eur J Clin Pharmacol; 2019 Jan; 75(1):21-31. PubMed ID: 30264164
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
Gupta AK; Maity C
Medicine (Baltimore); 2021 Jan; 100(3):e23641. PubMed ID: 33545934
[TBL] [Abstract][Full Text] [Related]
8. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
Ringel-Kulka T; McRorie J; Ringel Y
Am J Gastroenterol; 2017 Jan; 112(1):145-151. PubMed ID: 27845337
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
Sudha MR; Jayanthi N; Aasin M; Dhanashri RD; Anirudh T
Benef Microbes; 2018 Jun; 9(4):563-572. PubMed ID: 29695183
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
11. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study.
Madempudi RS; Neelamraju J; Ahire JJ; Gupta SK; Shukla VK
Probiotics Antimicrob Proteins; 2020 Jun; 12(2):335-342. PubMed ID: 30911991
[TBL] [Abstract][Full Text] [Related]
12. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial.
Mandel DR; Eichas K; Holmes J
BMC Complement Altern Med; 2010 Jan; 10():1. PubMed ID: 20067641
[TBL] [Abstract][Full Text] [Related]
13. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Airaksinen K; Yeung N; Lyra A; Lahtinen SJ; Huttunen T; Shanahan F; Ouwehand AC
Benef Microbes; 2019 Jul; 10(6):617-627. PubMed ID: 31131616
[TBL] [Abstract][Full Text] [Related]
14. The probiotic
Garvey SM; Mah E; Blonquist TM; Kaden VN; Spears JL
Gut Microbes; 2022; 14(1):2122668. PubMed ID: 36269141
[TBL] [Abstract][Full Text] [Related]
15. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
16. A Randomized, Double-blind, Placebo-controlled, Parallel Study Evaluating the Efficacy of Bacillus subtilis MB40 to Reduce Abdominal Discomfort, Gas, and Bloating.
Penet C; Kramer R; Little R; Spears JL; Parker J; Iyer JK; Guthrie N; Evans M
Altern Ther Health Med; 2021 Jun; 27(S1):146-157. PubMed ID: 31719214
[TBL] [Abstract][Full Text] [Related]
17. A probiotic amylase blend reduces gastrointestinal symptoms in a randomised clinical study.
La Monica MB; Raub B; Lopez HL; Ziegenfuss TN
Benef Microbes; 2023 Oct; 14(5):459-476. PubMed ID: 38350481
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic-Associated Gastrointestinal Symptoms in Children-Randomized, Double-Blind, Placebo-Controlled Study.
Olek A; Woynarowski M; Ahrén IL; Kierkuś J; Socha P; Larsson N; Önning G
J Pediatr; 2017 Jul; 186():82-86. PubMed ID: 28438377
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial.
Wauters L; Slaets H; De Paepe K; Ceulemans M; Wetzels S; Geboers K; Toth J; Thys W; Dybajlo R; Walgraeve D; Biessen E; Verbeke K; Tack J; Van de Wiele T; Hellings N; Vanuytsel T
Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):784-792. PubMed ID: 34358486
[TBL] [Abstract][Full Text] [Related]
20. [The effects of probiotics on symptoms of irritable bowel syndrome].
Kim YG; Moon JT; Lee KM; Chon NR; Park H
Korean J Gastroenterol; 2006 Jun; 47(6):413-9. PubMed ID: 16809947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
